Showing results (141-150 of 1,711) with videos related to
Sort By:
Pageof 172
Oncoimmunology|February 1, 2014
Trial Watch: Lenalidomide-based immunochemotherapyMichaela Semeraro, Erika Vacchelli, Alexander Eggermont, et al.Nature Reviews. Drug Discovery|May 23, 2017
Pharmacological modulation of autophagy: therapeutic potential and persisting obstaclesLorenzo Galluzzi, José Manuel Bravo-San Pedro, Beth Levine, et al.Oncoimmunology|September 28, 2013
Trial Watch: Immunostimulatory cytokinesErika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, et al.Biochemical Society Transactions|September 17, 2008
Life, death and burial: multifaceted impact of autophagyLorenzo Galluzzi, Eugenia Morselli, José Miguel Vicencio, et al.Oncoimmunology|March 14, 2013
Trial watch: Monoclonal antibodies in cancer therapyErika Vacchelli, Alexander Eggermont, Jérôme Galon, et al.Oncoimmunology|July 30, 2013
Trial watch: Oncolytic viruses for cancer therapyErika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, et al.Oncoimmunology|September 16, 2020
Trial Watch: experimental TLR7/TLR8 agonists for oncological indicationsGiorgio Frega, Qi Wu, Julie Le Naour, et al.Cell Cycle (Georgetown, Tex.)|December 21, 2012
Transgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterationsMohamed Jemaà, Lorenzo Galluzzi, Oliver Kepp, et al.Oncoimmunology|October 2, 2013
Trial Watch: Toll-like receptor agonists for cancer therapyErika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, et al.Apoptosis : an International Journal on Programmed Cell Death|February 13, 2007
Methods for the assessment of mitochondrial membrane permeabilization in apoptosisLorenzo Galluzzi, Naoufal Zamzami, Thibault de La Motte Rouge, et al.Pageof 172